Anthem Biosciences Limited — Profit & Loss Statement

₹656.25

+5.12%

Anthem Biosciences Limited Profit & Loss Statement (Annual)

Metric	2025	2024	2023	2022
Tax Effect Of Unusual Items	0.92 Cr	1.53 Cr	15.49 Cr	3.43 Cr
Tax Rate For Calcs	0.31	0.23	0.23	0.26
Normalized EBITDA	753.33 Cr	561.79 Cr	500.58 Cr	602.20 Cr
Total Unusual Items	2.93 Cr	6.63 Cr	68.70 Cr	13.34 Cr
Total Unusual Items Excluding Goodwill	2.93 Cr	6.63 Cr	68.70 Cr	13.34 Cr
Net Income From Continuing Operation Net Minority Interest	451.26 Cr	367.31 Cr	385.19 Cr	405.54 Cr
Reconciled Depreciation	89.37 Cr	81.82 Cr	63.77 Cr	57.84 Cr
Reconciled Cost Of Revenue	743.91 Cr	599.55 Cr	339.28 Cr	408.92 Cr
EBITDA	756.25 Cr	568.42 Cr	569.27 Cr	615.54 Cr
EBIT	666.88 Cr	486.59 Cr	505.50 Cr	557.70 Cr
Net Interest Income	54.17 Cr	31.20 Cr	20.38 Cr	-2.61 Cr
Interest Expense	10.02 Cr	9.28 Cr	8.20 Cr	11.56 Cr
Interest Income	64.70 Cr	40.86 Cr	29.10 Cr	9.58 Cr
Normalized Income	449.25 Cr	362.21 Cr	331.98 Cr	395.64 Cr
Net Income From Continuing And Discontinued Operation	451.26 Cr	367.31 Cr	385.19 Cr	405.54 Cr
Total Expenses	1.25K Cr	994.74 Cr	685.23 Cr	712.13 Cr
Rent Expense Supplemental	0.26 Cr	0.43 Cr	0.26 Cr	0.24 Cr
Diluted Average Shares	56.16 Cr	56.16 Cr	56.16 Cr	56.16 Cr
Basic Average Shares	56.16 Cr	56.16 Cr	56.16 Cr	56.16 Cr
Diluted EPS	8.04	6.54	6.86	7.22
Basic EPS	8.04	6.54	6.86	7.22
Diluted NI Availto Com Stockholders	451.26 Cr	367.31 Cr	385.19 Cr	405.54 Cr
Net Income Common Stockholders	451.26 Cr	367.31 Cr	385.19 Cr	405.54 Cr
Otherunder Preferred Stock Dividend	0.00	0.00	0.00	0.00
Net Income	451.26 Cr	367.31 Cr	385.19 Cr	405.54 Cr
Net Income Including Noncontrolling Interests	451.26 Cr	367.31 Cr	385.18 Cr	405.54 Cr
Net Income Continuous Operations	451.26 Cr	367.31 Cr	385.18 Cr	405.54 Cr
Tax Provision	205.61 Cr	110.01 Cr	112.11 Cr	140.60 Cr
Pretax Income	656.87 Cr	477.32 Cr	497.30 Cr	546.14 Cr
Other Non Operating Income Expenses	0.28 Cr	0.24 Cr	23.63 Cr	2.97 Cr
Special Income Charges	-4.65 Cr	-0.55 Cr	61.80 Cr	-0.26 Cr
Other Special Charges	4.62 Cr	0.43 Cr	-61.80 Cr	0.18 Cr
Write Off	0.02 Cr	0.12 Cr	0.00	0.08 Cr
Net Non Operating Interest Income Expense	54.17 Cr	31.20 Cr	20.38 Cr	-2.61 Cr
Total Other Finance Cost	0.51 Cr	0.38 Cr	0.52 Cr	0.63 Cr
Interest Expense Non Operating	10.02 Cr	9.28 Cr	8.20 Cr	11.56 Cr
Interest Income Non Operating	64.70 Cr	40.86 Cr	29.10 Cr	9.58 Cr
Operating Income	592.15 Cr	424.63 Cr	371.70 Cr	519.12 Cr
Operating Expense	508.49 Cr	395.19 Cr	345.95 Cr	303.21 Cr
Other Operating Expenses	129.65 Cr	94.01 Cr	94.89 Cr	81.71 Cr
Depreciation And Amortization In Income Statement	89.37 Cr	81.82 Cr	63.70 Cr	57.76 Cr
Amortization	2.51 Cr	3.70 Cr	3.43 Cr	2.66 Cr
Depreciation Income Statement	86.86 Cr	78.12 Cr	60.27 Cr	55.10 Cr
Research And Development	19.52 Cr	23.16 Cr	25.86 Cr	24.79 Cr
Selling General And Administration	14.48 Cr	13.51 Cr	12.50 Cr	10.63 Cr
Selling And Marketing Expense	5.45 Cr	5.30 Cr	5.68 Cr	5.43 Cr
General And Administrative Expense	9.03 Cr	8.21 Cr	6.81 Cr	5.20 Cr
Rent And Landing Fees	0.26 Cr	0.43 Cr	0.26 Cr	0.24 Cr
Gross Profit	1.10K Cr	819.82 Cr	717.65 Cr	822.33 Cr
Cost Of Revenue	743.91 Cr	599.55 Cr	339.28 Cr	408.92 Cr
Total Revenue	1.84K Cr	1.42K Cr	1.06K Cr	1.23K Cr
Operating Revenue	1.84K Cr	1.42K Cr	1.06K Cr	1.23K Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Anthem Biosciences Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Biotechnology Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.